Inventor · disambiguated record
Paolo Mascagni
Also filed as: MASCAGNI PAOLO
21 granted patents·4 pending applications·273 citations·filing 1994–2021
94Inventor score
Top patents by PatentIndex Score
25 records- 0192US7157099B2Sustained release pharmaceutical compositions for the parenteral administration of hydrophilic compoundsITALFARMACO SPA·Filed 2001·Granted Jan 2, 2007·127 cites·22 claims
- 0287US5905090AAnalogues of the active metabolite of leflunomideITALFARMACO SPA·Filed 1998·Granted May 18, 1999·49 cites·3 claims
- 0385US7329689B2Monohydrate hydrochloride of the 4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylaminomethyl-naphtalen-2-yl) esterITALFARMACO SPA·Filed 2005·Granted Feb 12, 2008·9 cites·2 claims
- 0479US7635788B2Alpha-amino acid derivatives with antiinflammatory activityITALFARMACO SPA·Filed 2005·Granted Dec 22, 2009·4 cites·9 claims
- 0572US6034096ACompounds with anti-inflammatory and immunosuppressive activitiesITALFARMACO SPA·Filed 1997·Granted Mar 7, 2000·39 cites·15 claims
- 0668US8765150B2Riluzole aqueous suspensionsARTICO ROBERTA·Filed 2010·Granted Jul 1, 2014·5 cites·18 claims
- 0767US7235689B2Hydroxamic acid derivatives having anti-inflammatory actionITALFARMACO SPA·Filed 2004·Granted Jun 26, 2007·4 cites·14 claims
- 0866US9867799B2Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophyITALFARMACO SPA·Filed 2016·Granted Jan 16, 2018·1 cites·16 claims
- 0966US6057295AOligopeptides derived from C-reactive protein fragmentsITALFARMACO SPA·Filed 1994·Granted May 2, 2000·20 cites·3 claims
- 1065US9421184B2Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophyITALFARMACO SPA·Filed 2014·Granted Aug 23, 2016·1 cites·13 claims
- 1165US6984632B1Complexes of paroxetine, with cyclodextrins or cyclodextrin derivativesITALFARMACO SPA·Filed 2000·Granted Jan 10, 2006·2 cites·24 claims
- 1259US2021128512A1Use of histone deacetylase inhibitors for the care of philadelphia-negative myeloproliferative syndromesITALFARMACO SPA·Filed 2021·Application pending·0 cites
- 1351US9522127B2Use of histone deacetylase inhibitors for the care of philadelphia-negative myeloproliferative syndromesITALFARMACO SPA·Filed 2013·Granted Dec 20, 2016·0 cites·9 claims
- 1450US8637702B2Derivatives of N-hydroxybenzamide for treating HIV infectionsDINARELLO CHARLES·Filed 2010·Granted Jan 28, 2014·0 cites·10 claims
- 1547US6342481B1Oligopeptides derived from C-reactive protein fragmentsITALFARMACO SPA·Filed 1999·Granted Jan 29, 2002·7 cites·6 claims
- 1646US8937152B2Non-selective somatostatin analoguesVITALI ANDREA·Filed 2008·Granted Jan 20, 2015·0 cites·31 claims
- 1744US8227515B2Use of hydroxamic acid derivatives for the preparation of anti-tumour medicamentsLEONI FLAVIO·Filed 2003·Granted Jul 24, 2012·0 cites·4 claims
- 1844US2017049740A1Use of histone deacetylase inhibitors for the care of philadelphia-negative myeloproliferative syndromesITALFARMACO SPA·Filed 2016·Application pending·0 cites
- 1943US7427620B2Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromesITALFARMACO SPA·Filed 2004·Granted Sep 23, 2008·0 cites·8 claims
- 2038US2011294892A1Use of histone deacetylase inhibitors for the care of Philadephia-negative myeloproliferative syndromesOLDONI TIZIANO·Filed 2011·Application pending·0 cites
- 2137US10590101B2Benzo-N-hydroxy amide compounds having antitumor activityITALFARMACO SPA·Filed 2017·Granted Mar 17, 2020·0 cites·10 claims
- 2237US8217079B2Method for treating Philadelphia-negative myeloproliferative syndromesMASCAGNI PAOLO·Filed 2010·Granted Jul 10, 2012·0 cites·16 claims
- 2333US2004157930A1Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugsFiled 2002·Application pending·0 cites
- 2432US5856305APeptides endowed with antiinflammatory activityITALFARMACO SPA·Filed 1995·Granted Jan 5, 1999·5 cites·3 claims
- 2531US10688047B2Physically and chemically stable oral suspensions of givinostatITALFARMACO SPA·Filed 2016·Granted Jun 23, 2020·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →